Trinity Biotech Names Louise Tallon as CFO to Drive Financial Growth

Tuesday, 9 July 2024, 20:28

Trinity Biotech has announced the appointment of Louise Tallon as CFO, with the strategic goal of achieving $20M EBITDASO on $75M revenues by Q2 2025. Tallon's expertise is expected to contribute to the company's financial performance and overall success.

LivaRava Finance Meta Image — Trinity Biotech Names Louise Tallon as CFO to Drive Financial Growth

Trinity Biotech Names Louise Tallon as CFO

Trinity Biotech has appointed Louise Tallon as CFO with the aim of reaching $20M EBITDASO on $75M revenues by Q2 2025. Tallon's expertise and experience are valuable assets for driving the company's financial growth.

Strategic Financial Goals

$20M EBITDASO: Target set for improved operational efficiency.
$75M Revenues: Revenue target by Q2 2025.

Trinity Biotech's decision to appoint Louise Tallon as CFO reflects the company's focus on financial performance and future stability.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.